Based on these observations, we hypothesized that it should be possible to derive tumor antigen-specific TCR sequences from allogeneic donor lymphocytes with MHC-mismatched MHC multimers, independent of in vitro cell propagation. This evidence concerns the gene HLA-C and neoplasm.